Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201311119 Principal Investigator: Ma, Cynthia
Title: A Phase I, multi-center, non-randomized, open-label, dose escalation design study to characterize safety, tolerability, pharmacokinetics and maximum tolerated dose of BAY 1125976 in subjects with advanced solid tumors
Phase: I Disease Site: Breast, Female
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to identify the most appropriate dose of the study drug BAY1125976 (in terms of tolerability), and secondly to see if it is efficient to treat advanced solid tumors, especially metastatic breast cancers.
 
More Information:
clinicaltrials.gov
Internal Protocol Documents (requires Siteman administrative database password)